First Trust Advisors’s Clovis Oncology, Inc. CLVS Stock Holding History

First Trust Advisors’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-48,598	Closed	-$723K	–	2517
2019 Q2	$723K	Buy	+48,598	New	+$878K	﹤0.01%	1986
2015 Q4	–	Sell	-36,683	Closed	-$3.37M	–	2327
2015 Q3	$3.37M	Buy	36,683 +13,877	+61%	+$1.2M	0.01%	1127
2015 Q2	$2M	Buy	22,806 +4,741	+26%	+$406K	0.01%	1539
2015 Q1	$1.34M	Buy	+18,065	New	+$1.28M	﹤0.01%	1646
2014 Q2	–	Sell	-18,749	Closed	-$1.3M	–	2311
2014 Q1	$1.3M	Buy	18,749 +7,012	+60%	+$515K	0.01%	1576
2013 Q4	$707K	Buy	11,737 +5,820	+98%	+$317K	﹤0.01%	1769
2013 Q3	$360K	Buy	5,917 +2,528	+75%	+$179K	﹤0.01%	2036
2013 Q2	$227K	Buy	+3,389	New	+$152K	﹤0.01%	2122

Other funds holding CLVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

ECP

Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

First Trust Advisors's CLVS Position: Q3 2019 in Review

First Trust Advisors sold out of Clovis Oncology, Inc. (CLVS) in Q3 2019, closing a stake of 48,598 shares — an estimated $723K sold.

First Trust Advisors first reported a position in CLVS in Q2 2013 and held it in 8 quarters. The position peaked at $3.37M in Q3 2015. 153 funds tracked by Wall St. Rank hold CLVS as of Q3 2019.

First Trust Advisors reported no remaining Clovis Oncology, Inc. position as of Q3 2019 after selling out during the quarter.
First Trust Advisors sold 48,598 Clovis Oncology, Inc. shares in Q3 2019, an estimated $723K.
First Trust Advisors first reported a position in Clovis Oncology, Inc. in Q2 2013 and held it in 8 quarters.
First Trust Advisors's Clovis Oncology, Inc. position peaked at $3.37M in Q3 2015.
153 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q3 2019.

Based on First Trust Advisors's 13F filing for Q3 2019, filed 4 Nov 2019.